Clinical Trial Update: Clinical Study to Investigate the Biological Activity, Safety, Tolerability, and Pharmacokinetics of Ponesimod in Subjects With Symptomatic Chronic GVHD [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the biological activity, safety, tolerability, and pharmacokinetics of ponesimod in symptomatic chronic graft-versus-host disease was t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Ponesimod (ponesimod)

Snippet

Sponsor: Actelion | Conditions: Chronic Graft Versus Host Disease | Phase 2 | Status: TERMINATED | Results posted: 2018-05-09